Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Allografting

Granzymes A and B serum levels in allo-SCT

Bone Marrow Transplantation volume 43, pages 787–791 (2009)Cite this article

Abstract

Activated cytotoxic T lymphocytes and natural killer cells, which are involved in the pathogenesis of GVHD and viral infections after SCT produce granzymes (Grs). This study performed an ELISA in the serum of 86 patients at various time points before and after Allo-SCT to investigate GrA and GrB levels as potential markers for these serious complications. The increase in Gr levels from the day of transplantation until the appearance of the complication was highly predictive. If GrA increased to three times its pretransplant level, the cumulative incidence of developing acute GVHD was 73% and for CMV infection 68%, in comparison with 45 and 35%, respectively, for patients without these complications. A strong increase in GrA level correlated with clinical severity of acute GVHD. No correlation was observed with early relapse or long-term overall survival. In addition to clinical parameters, a strong increase in GrA levels was identified as an independent marker for the occurrence of acute GVHD as well as for CMV infection. Similar effects were observed with GrB. In conclusion, Gr protein levels can also be used as a marker for complications after Allo-SCT.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Pipkin ME, Lieberman J . Delivering the kiss of death: progress on understanding how perforin works. Curr Opin Immunol 2007; 19: 301–308.

    Article  CAS  Google Scholar 

  2. Braun MY, Lowin B, French L, Acha-Orbea H, Tschopp J . Cytotoxic T cells deficient in both functional Fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal graft-versus-host disease. Blood 1996; 183: 657–661.

    CAS  Google Scholar 

  3. Baker MB, Altman NH, Podack ER, Levy RB . The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice. J Exp Med 1996; 183: 2645–2656.

    Article  CAS  PubMed  Google Scholar 

  4. Schmaltz C, Alpdogan O, Horndasch KJ, Muriglan SJ, Kappel BJ, Teshima T et al. Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect. Blood 2001; 97: 2886–2895.

    Article  CAS  PubMed  Google Scholar 

  5. Graubert TA, Russell JH, Ley TJ . The role of granzyme B in murine models of acute graft-versus-host disease and graft rejection. Blood 1996; 87: 1232–1237.

    CAS  PubMed  Google Scholar 

  6. Graubert TA, DiPersio JF, Russell JH, Ley TJ . Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation. J Clin Invest 1997; 100: 904–911.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Takata M . Immunohistochemical identification of perforin-positive cytotoxic lymphocytes in graft-versus-host disease. Am J Clin Pathol 1995; 103: 324–329.

    Article  CAS  PubMed  Google Scholar 

  8. Higaki Y, Yamada O, Okamura T, Mizoguchi H, Kawashima M . Granzyme-B-containing lymphocyte involvement in epidermal injury in graft-versus-host disease. Dermatology 2001; 202: 94–98.

    Article  CAS  PubMed  Google Scholar 

  9. Jaksch M, Uzunel M, Martinez Cangana G, Remberger M, Mattsson J . Increased levels of immune transcript in patients with acute GvHD after allogeneic stem cell transplantation. Bone Marrow Transplant 2003; 31: 183–190.

    Article  CAS  PubMed  Google Scholar 

  10. Jaksch M, Remberger M, Mattsson J . Increased immune transcript levels are correlated with acute graft-versus-host disease and cytomegalovirus response after allogeneic stem cell transplantation. Transplantation 2004; 77: 195–200.

    Article  PubMed  Google Scholar 

  11. Kircher B, Hack CE, Dickinson AM, Wang XN, Oudshoorn M, Sachs A et al. Towards functional transplant donor matching by measurement of granzyme A and granzyme B production levels. J Immunol Methods 2004; 293: 51–59.

    Article  CAS  PubMed  Google Scholar 

  12. Nachbaur D, Eibl B, Kropshofer G, Meister B, Mitterschiffthaler A, Schennach H et al. In vivo T cell depletion with low-dose rabbit antithymocyte globulin results in low transplant-related mortality and low relapse incidence following unrelated hematopoietic stem cell transplantation. J Hematother Stem Cell Res 2002; 11: 731–737.

    Article  CAS  PubMed  Google Scholar 

  13. Kaplan EL, Meier P . Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481.

    Article  Google Scholar 

  14. Spaeny-Dekking EHA, Hanna WL, Wolbink AM, Wever PC, Kummer AJ, Swaak AJG et al. Extracellular granzymes A and B in humans: detection of native species during CTL responses in vitro and in vivo. J Immunol 1998; 160: 3610–3616.

    CAS  PubMed  Google Scholar 

  15. Clément MV, Haddad P, Soulié A, Benvenuti C, Lichtenheld MG, Podack ER et al. Perforin and granzyme B as markers for acute rejection in heart transplantation. Int Immunol 1991; 3: 1175–1181.

    Article  PubMed  Google Scholar 

  16. Griffiths GM, Namikawa R, Mueller C, Liu C-C, Young J D-E, Billingham M et al. Granzyme A and perforin as markers for rejection in cardiac transplantation. Eur J Immunol 1991; 21: 687–693.

    Article  CAS  PubMed  Google Scholar 

  17. Cashion AK, Sabek OM, Driscoll CJ, Gaber LW, Gaber AO . Serial peripheral blood cytotoxic lymphocyte gene expression measurements for prediction of pancreas transplant rejection. Transplant Proc 2006; 38: 3676–3677.

    Article  CAS  PubMed  Google Scholar 

  18. Kummer JA, Wever PC, Kamp AM, ten Berge IJ, Hack CE, Weening JJ . Expression of granzyme A and B proteins by cytotoxic lymphocytes involved in acute renal allograft rejection. Kidney Int 1995; 47: 70–77.

    Article  CAS  PubMed  Google Scholar 

  19. Veale JL, Liang LW, Zhang Q, Gjertson DW, Du Z, Bloomquist EW et al. Noninvasive diagnosis of cellular and antibody-mediated rejection by perforin and granzyme B in renal allografts. Hum Immunol 2006; 67: 7777–7786.

    Article  Google Scholar 

  20. Strehlau J, Pavlakis M, Lipman M, Maslinski W, Shapiro M, Strom TB . The intragraft gene activation of markers reflecting T-cell-activation and –cytotoxicity analyzed by quantitative RT-PCR in renal transplantation. Clin Nephrol 1996; 46: 30–33.

    CAS  PubMed  Google Scholar 

  21. Inkinen K, Lahesmaa R, Brandt A, Katajamaa M, Halme L, Hockerstedt K et al. DNA microarray-based gene expression profiles of cytomegalovirus infection and acute rejection in liver transplants. Transplant Proc 2005; 37: 1227–1229.

    Article  CAS  PubMed  Google Scholar 

  22. Clément MV, Legros-Maïda S, Israël-Biet D, Carnot F, Soulié A, Reynaud P et al. Perforin and granzyme B expression is associated with severe acute rejection. Evidence for in situ localization in alveolar lymphocytes of lung-transplanted patients. Transplantation 1994; 57: 322–326.

    Article  PubMed  Google Scholar 

  23. Bittmann I, Müller C, Behr J, Groetzner J, Frey L, Löhrs U . Fas/FasL and perforin/granzyme pathway in acute rejection and diffuse alveolar damage after allogeneic lung transplantation-a human biopsy study. Virchows Arch 2004; 445: 375–381.

    Article  PubMed  Google Scholar 

  24. Han D, Xu X, Baidal D, Leith J, Ricordi C, Alejandro R et al. Assessment of cytotoxic lymphocyte gene expression in the peripheral blood of human islet allograft recipients: elevation precedes clinical evidence of rejection. Diabetes 2004; 53: 2281–2290.

    Article  CAS  PubMed  Google Scholar 

  25. Altimari A, Gruppioni E, Capizzi E, Bagni A, Corti B, Fiorentino M et al. Blood monitoring of granzyme B and perforin expression after intestinal transplantation: Considerations on clinical relevance. Transplantation 2008; 85: 1778–1783.

    Article  PubMed  Google Scholar 

  26. ten Berge IJ, Wever PC, Wolbink AM, Surachno J, Wertheim PM, Spaeny LH et al. Increased systemic levels of soluble granzymes A and B during primary cytomegalovirus infection after renal transplantation. Transplant Proc 1998; 30: 3972–3974.

    Article  CAS  PubMed  Google Scholar 

  27. Wever PC, Spaeny LH, van der Vliet HJ, Rentenaar RJ, Wolbink AM, Surachno J et al. Expression of granzyme B during primary cytomegalovirus infection after renal transplantation. J Infect Dis 1999; 179: 693–696.

    Article  CAS  PubMed  Google Scholar 

  28. Rowshani AT, Strik MC, Molenaar R, Yong SL, Wolbink AM, Bemelman FJ et al. The granzyme B inhibitor SERPINB9 (proteinase inhibitor 9) circulates in blood and increases on primary cytomegalovirus infection after renal transplantation. J Infect Dis 2005; 192: 1908–1911.

    Article  CAS  PubMed  Google Scholar 

  29. Pan L, Teshima T, Hill GR, Bungard D, Brinson YS, Reddy VS et al. Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host disease. Blood 1999; 93: 4071–4078.

    CAS  PubMed  Google Scholar 

  30. Tsukada N, Kobata T, Aizawa Y, Yagita H, Okumura K . Graft-versus-leukemia effect and graft-versus-host disease can be differentiated by cytotoxic mechanisms in a murine model of allogeneic bone marrow transplantation. Blood 1999; 93: 2738–2747.

    CAS  PubMed  Google Scholar 

  31. Hsieh MH, Korngold R . Differential use of FasL- and perforin-mediated cytolytic mechanisms by T-cell subsets involved in graft-versus-myeloid leukemia responses. Blood 2000; 96: 1047–1055.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine V—Hematology and Oncology, Immunobiology and Stem Cell Laboratory, Innsbruck Medical University, Innsbruck, Austria

    B Kircher, P Schumacher & D Nachbaur

Authors
  1. B Kircher
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P Schumacher
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D Nachbaur
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B Kircher.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kircher, B., Schumacher, P. & Nachbaur, D. Granzymes A and B serum levels in allo-SCT. Bone Marrow Transplant 43, 787–791 (2009). https://doi.org/10.1038/bmt.2008.395

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2008.395

Keywords

This article is cited by

Search

Advanced search

Quick links